IT-enabled Clinical Firm Thyrocare Technologies posts Net Profit of Rs. 21.70 Crores

After reporting a 22.05 percent increase in consolidated net profit to Rs. 21.70 crore in Q4 FY25 over Q4 FY24, and a 21.34 percent increase in operating revenue to Rs. 187.16 crore, Thyrocare Technologies saw a 15 percent spike to Rs. 884.20.

The March quarter's profit before tax (PBT) was Rs. 47.19 crore, a strong 106.07 percent increase over the Rs. 22.90 crore recorded during the same period the previous year.

During the quarter, total expenses increased 6.92 percent year over year to Rs. 143.93 crore. During the year under review, the cost of materials utilized was Rs. 48.71 crore (up 5.62 percent YoY), while employee benefits expenses were Rs 33.47 crore (up 25.97 percent).

In Q4 FY25, the company's revenue from Imaging Services was Rs 13.68 crore, up 7.2 percent YoY, while its revenue from Diagnostic Testing Services was Rs. 172.69 crore, up 22.38 percent YoY.

In the March 2025 quarter, EBITDA increased 70 percent year over year to Rs. 57.4 crore from Rs. 33.8 crore in the same period the year before. In Q4 of FY25, the EBITDA margin climbed to 31 percent from 22 percent in the same quarter of the previous fiscal year.

Subject to shareholder approval, the Board has suggested a final dividend of Rs. 21 per equity share for FY25.

Thyrocare Technologies works in the healthcare sector and offers hospitals, labs, and patients in India high-quality diagnostic services at reasonable prices.